X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

SYRS

Closed

Syros Pharmaceuticals Inc

0.0232
+0.0010 (+4.50%)
Last Update: 01 Jul 2025 22:59:00
Yesterday: 0.0222
Day's Range: 0.022 - 0.025
Send
When Written:
 
2.76
Syros Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing treatments for cancer and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts. Syros is known for its gene control platform, which allows for the identification of new drug targets and the development of precision medicines. The company's lead product candidate is SY-1425, a selective retinoic acid receptor alpha agonist currently in clinical trials for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Syros has partnerships with several pharmaceutical companies and has received funding from various sources, including venture capital firms and government grants.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X